Academic Cardiologist @AcademicTruther

Not a surprise at all. Love this! Go to the Sunshine Act Database and look at how much money one "thought leader" gets from @Abiomed It's an complete disgrace openpaymentsdata.cms.gov/physician/3592… @NavinKapur4

John Mandrola, MD @drjohnm

2 weeks ago

Not a surprise at all. Love this! Go to the Sunshine Act Database and look at how much money one "thought leader" gets from @Abiomed It's an complete disgrace openpaymentsdata.cms.gov/physician/3592… @NavinKapur4

keyboard_arrow_left Previous keyboard_arrow_right Next

15 58 220 59K 63

Download Image

There's THT. ACC. ISHLT. And now, Houston Shock symposium. Maybe shock outcomes would be better if docs spent more time managing patients than attending meetings? Then again, meetings are attended by thought leaders who are better with speaking than patient care.

HoustonShock @HoustonShockHSS

a month ago

There's THT. ACC. ISHLT. And now, Houston Shock symposium. Maybe shock outcomes would be better if docs spent more time managing patients than attending meetings? Then again, meetings are attended by thought leaders who are better with speaking than patient care.

3 7 21 10K 0

Download Image

The HFSA needs to tell CV fellows that you can have a rewarding career in HF by seeing patients and don't have to play the academic "game" of crappy salaries, writing pointless articles, and serving under toxic chiefs. Spotlighting Drazner accomplishes nothing.

Bernard Kadosh @KadoshBernard

2 months ago

The HFSA needs to tell CV fellows that you can have a rewarding career in HF by seeing patients and don't have to play the academic "game" of crappy salaries, writing pointless articles, and serving under toxic chiefs. Spotlighting Drazner accomplishes nothing.

1 8 27 8K 2

Single-arm. No control group. Zero evidence of benefit. Amazing the junk science at #THT2024. Too bad @drjohnm isn't on site to rip these "studies" to shreds.

Omid Forouzan @1heartguy

2 months ago

Single-arm. No control group. Zero evidence of benefit. Amazing the junk science at #THT2024. Too bad @drjohnm isn't on site to rip these "studies" to shreds.

keyboard_arrow_left Previous keyboard_arrow_right Next

0 4 13 2K 1

Download Image

HF patients are not put on medications that improve mortality, but this guy is worried about expensive technologies that barely improve 6 minute walk distance? This is what happens when thought leaders are more interested in attending meetings than patient care. @NirUrielMD

Eiran Gorodeski, MD, MPH @EiranGorodeski

2 months ago

HF patients are not put on medications that improve mortality, but this guy is worried about expensive technologies that barely improve 6 minute walk distance? This is what happens when thought leaders are more interested in attending meetings than patient care. @NirUrielMD

1 5 23 3K 1

Download Image

All authors have significant conflict of interest. One author even owns stock in a company which makes one of the devices mentioned in article. Disclosure system is broken if authors can boost stock portfolio by writing editorial pieces. Retract it @JCardFail @preventfailure

Anu Lala-Trindade @dranulala

2 months ago

All authors have significant conflict of interest. One author even owns stock in a company which makes one of the devices mentioned in article. Disclosure system is broken if authors can boost stock portfolio by writing editorial pieces. Retract it @JCardFail @preventfailure

keyboard_arrow_left Previous keyboard_arrow_right Next

0 8 25 3K 2

Download Image

Best decision Pollard made was leaving Indiana to get his transplant elsewhere. The dirty secret in transplant medicine? Some centers suck at it and both heart transplant centers in Indiana are struggling big time. Great news that Pollard got his heart.

Scot Pollard @ScotPollard31

3 months ago

Best decision Pollard made was leaving Indiana to get his transplant elsewhere. The dirty secret in transplant medicine? Some centers suck at it and both heart transplant centers in Indiana are struggling big time. Great news that Pollard got his heart.

133 74 4K 285K 11

Download Image

this "meta-analysis" combines data from CardioMEMS with a trial using HeartPOD LAP sensor which isn't even commercially available. Combining two different technologies in a meta-analysis? How much did Joann Lindenfeld get paid for this analysis? Do better #JACC @JACCJournals

ACC Media Center @ACCmediacenter

2 months ago

this "meta-analysis" combines data from CardioMEMS with a trial using HeartPOD LAP sensor which isn't even commercially available. Combining two different technologies in a meta-analysis? How much did Joann Lindenfeld get paid for this analysis? Do better #JACC @JACCJournals

1 1 0 1K 0

The data is not that strong. More patients will undergo an unnecessary procedure and get no benefit. Believe the data, not a doc making over $100K in consulting fees from device companies. openpaymentsdata.cms.gov/physician/54824 #OnTheTake

Paul @psorajja

2 months ago

The data is not that strong. More patients will undergo an unnecessary procedure and get no benefit. Believe the data, not a doc making over $100K in consulting fees from device companies. openpaymentsdata.cms.gov/physician/54824 #OnTheTake

4 17 101 8K 0

Download Image

Not a surprise. The attendings who have the most impressive CVs in terms of publications are often the the doctors you least want to take care of your patients. I work with a prominent HF thought leader. He/she is incredibly lazy and has no idea how to assess a patient

Ash Paul @pash22

3 months ago

Not a surprise. The attendings who have the most impressive CVs in terms of publications are often the the doctors you least want to take care of your patients. I work with a prominent HF thought leader. He/she is incredibly lazy and has no idea how to assess a patient

5 9 39 15K 9

10 of 11 Directors of #THT2024 made $148K in 2022 alone based on Sunshine Act database in consulting fees, travel/lodging, free meals, and honoraria. And then there is the 11th Director (NK) who made $412,000 in 2022 alone in freebies. #THT2024 is pure industry. Not education

Manreet Kanwar @manreetkanwar

3 months ago

10 of 11 Directors of #THT2024 made $148K in 2022 alone based on Sunshine Act database in consulting fees, travel/lodging, free meals, and honoraria. And then there is the 11th Director (NK) who made $412,000 in 2022 alone in freebies. #THT2024 is pure industry. Not education

2 13 43 17K 0

Download Video

Why are transplant outcomes poor in Indiana? Examine the data that is public from SRTR.org One year survival at IU is 80% One year survival at St Vincent is 86% Both below national average. What's the problem?

annemariewthr @AnneMarieWTHR

3 months ago

Why are transplant outcomes poor in Indiana? Examine the data that is public from SRTR.org One year survival at IU is 80% One year survival at St Vincent is 86% Both below national average. What's the problem?

13 23 160 68K 6

Download Image

Don't forget CCM (Optimizer) and Barostim. I'm sure the RDN "thought leaders" are ready and able to sell their souls to earn an extra buck to tell everybody how great the technology is.

Sanjay Kaul @kaulcsmc

4 months ago

Don't forget CCM (Optimizer) and Barostim. I'm sure the RDN "thought leaders" are ready and able to sell their souls to earn an extra buck to tell everybody how great the technology is.

4 5 20 74K 4

Agree. Let's stop telling trainees that they need to listen to nurses b/c nurses are always right. yes, listen to multiple team members. But look at how hospitals are run by nursing administrators instead of physicians nowadays. You went to medical school for a reason.

Dorian L. Beasley MD, FACC @cardiojaydoc02

4 months ago

Agree. Let's stop telling trainees that they need to listen to nurses b/c nurses are always right. yes, listen to multiple team members. But look at how hospitals are run by nursing administrators instead of physicians nowadays. You went to medical school for a reason.

5 18 48 5K 0

Download Image

Seems excessive but the fact that a patient with LVAD underwent heart transplant surgery WITHOUT a chest CT being done to document anatomy after VAD placement is extreme negligence. Emory and the surgeon deserved to lose.

Jorge Estevez @jesteveztv

5 months ago

Seems excessive but the fact that a patient with LVAD underwent heart transplant surgery WITHOUT a chest CT being done to document anatomy after VAD placement is extreme negligence. Emory and the surgeon deserved to lose.

1 1 2 576 0

Agree 100%. Those same doctors for fight over authorship are the same who provide bad patient care that requires the "clean-up" of clinicians who do a much better job.

Aaron Goodman - “Papa Heme” @AaronGoodman33

4 months ago

Agree 100%. Those same doctors for fight over authorship are the same who provide bad patient care that requires the "clean-up" of clinicians who do a much better job.

11 11 210 33K 2

Shocking. Article written by paid consultants of Abbott is telling everybody how great the HM3 is.

EHJ Editor-in-Chief @ehj_ed

5 months ago

Shocking. Article written by paid consultants of Abbott is telling everybody how great the HM3 is.

1 16 45 7K 6

Download Image

Clinical trials have shown the benefit of CCM is modest. No survival benefit. @AndrewJSauer received close to $10,000 in honoraria from Impulse Dynamics (company that makes CCM device) in 2022. I'm sure his Grand Rounds talk was unbiased and fair. openpaymentsdata.cms.gov/physician/1227…

Linda Gillam MD, MPH, MACC, FASE, FAHA, FESC @LindaGillamMD

6 months ago

Clinical trials have shown the benefit of CCM is modest. No survival benefit. @AndrewJSauer received close to $10,000 in honoraria from Impulse Dynamics (company that makes CCM device) in 2022. I'm sure his Grand Rounds talk was unbiased and fair. openpaymentsdata.cms.gov/physician/1227…

1 4 16 3K 0

Download Image

More non-randomized data supposedly showing benefit of Impella. There is a reason @Abiomed has no interest in conducting a good study on Impella. They are too scared it will be negative. See how much @Abiomed pays @Babar_Basir @HenryFordHealth openpaymentsdata.cms.gov/physician/1318…

JAHA @JAHA_AHA

5 months ago

More non-randomized data supposedly showing benefit of Impella. There is a reason @Abiomed has no interest in conducting a good study on Impella. They are too scared it will be negative. See how much @Abiomed pays @Babar_Basir @HenryFordHealth openpaymentsdata.cms.gov/physician/1318…

1 8 30 6K 6

Download Image

Excellent. Of course some in the ACC who claim to care about diversity clearly do not.

Norman C. Wang, MD, MS @norman_c_wang

5 years ago

Excellent. Of course some in the ACC who claim to care about diversity clearly do not.

2 3 21 0 4

Download Image